Question 1

What is the catalog number for GNE-375?

Accepted Answer

The catalog number for GNE-375 is M13018.

Question 2

What sizes are available for GNE-375?

Accepted Answer

GNE-375 is available in the following size(s): 1 g, 200 mg, 500 mg, 5 mg, 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does GNE-375 come in?

Accepted Answer

GNE-375 is available in 7 different pack sizes.

Question 4

Is GNE-375 in stock?

Accepted Answer

GNE-375 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is GNE-375 used for?

Accepted Answer

GNE-375 is a potent, selective BRD9 inhibitor with IC50 of 5 nM.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 7

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Question 8

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

GNE-375

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

TRIM16 (Tripartite Motif-containing Protein 16, Estrogen-responsive B Box Protein, EBBP) (MaxLight 750) discontinued

SARM1 Protein, Human, Recombinant (His & Myc)

SARM1 Protein, Human, Recombinant (His & Myc)

SARM1 Protein, Human, Recombinant (His & Myc)

SARM1 Protein, Human, Recombinant (His & Myc)

SARM1 Protein, Human, Recombinant (His & Myc)